Healthcare Sector
Major Pharmaceutical Preparations Industry 
|
|
|
Data by Company within Major Pharmaceutical Preparations Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Abeona Therapeutics Inc. |
$ 954 |
$ 1 |
$ -27 |
- |
| Abbott Laboratories |
$ 104,042 |
$ 27,390 |
$ 477 |
77,000 |
| Arbutus Biopharma Corp |
$ 300 |
$ 11 |
$ -84 |
- |
| Acadia Pharmaceuticals Inc |
$ 2,470 |
$ 125 |
$ -289 |
- |
| Achillion Pharmaceuticals Inc |
$ 503 |
- |
$ -69 |
- |
| Acelrx Pharmaceuticals Inc |
$ 119 |
$ 8 |
$ -52 |
- |
| Acura Pharmaceuticals, Inc |
$ 9 |
$ 7 |
$ -2 |
- |
| Alcobra Ltd. |
- |
- |
$ 0 |
- |
| Adamis Pharmaceuticals Corp |
$ 131 |
$ 13 |
$ -26 |
- |
| Adamas Pharmaceuticals Inc |
$ 648 |
- |
$ -89 |
- |
| Aduro Biotech, Inc. |
$ 1,030 |
$ 17 |
$ -92 |
- |
| Advaxis, Inc. |
$ 68 |
$ 10 |
$ -97 |
- |
| Aegerion Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Agios Pharmaceuticals Inc |
$ 4,224 |
$ 43 |
$ -315 |
- |
| Aeglea Biotherapeutics, Inc. |
$ 131 |
$ 5 |
$ -27 |
- |
| Agile Therapeutics Inc |
$ 94 |
- |
$ -28 |
- |
| Aimmune Therapeutics, Inc. |
$ 1,608 |
- |
$ -131 |
- |
| Achaogen Inc |
$ 569 |
$ 11 |
$ -126 |
- |
| Akebia Therapeutics, Inc. |
$ 441 |
$ 178 |
$ -77 |
- |
| Akorn Inc |
$ 2,464 |
$ 841 |
$ -25 |
- |
| Albireo Pharma, Inc. |
$ 297 |
- |
$ -24 |
- |
| Aldeyra Therapeutics, Inc. |
$ 134 |
- |
$ -22 |
- |
| Alimera Sciences Inc |
$ 77 |
$ 36 |
$ -22 |
- |
| Alkermes Plc. |
$ 7,082 |
$ 903 |
$ -158 |
- |
| Alnylam Pharmaceuticals, Inc. |
$ 9,616 |
$ 94 |
$ -500 |
- |
| Alexza Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Alexion Pharmaceuticals Inc |
$ 24,315 |
$ 3,551 |
$ 443 |
2,273 |
| Amag Pharmaceuticals Inc. |
$ 673 |
$ 610 |
$ -199 |
- |
| Amylin Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Ampio Pharmaceuticals, Inc. |
$ 237 |
- |
$ -52 |
- |
| Amphastar Pharmaceuticals, Inc. |
$ 951 |
$ 240 |
$ -2 |
- |
| Amarin Corp Plcuk |
$ 796 |
$ 181 |
$ -68 |
- |
| Anacor Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Ani Pharmaceuticals Inc |
$ 693 |
$ 177 |
$ -1 |
- |
| Antriabio, Inc. |
$ 43 |
- |
$ -27 |
- |
| Anthera Pharmaceuticals Inc |
$ 4 |
- |
$ -27 |
- |
| Apricus Biosciences, Inc. |
$ 4 |
- |
$ 0 |
- |
| Aquinox Pharmaceuticals, Inc |
$ 295 |
- |
$ -50 |
- |
| Ardelyx, Inc. |
$ 231 |
- |
$ -64 |
- |
| Argos Therapeutics Inc |
$ 12 |
$ 2 |
$ -44 |
- |
| Aralez Pharmaceuticals Inc. |
$ 93 |
$ 106 |
$ -125 |
- |
| Arena Pharmaceuticals Inc |
$ 1,200 |
$ 21 |
$ -93 |
- |
| Arqule Inc |
$ 245 |
- |
$ -29 |
- |
| Array Biopharma Inc |
$ 2,816 |
$ 139 |
$ -137 |
- |
| Athersys, Inc |
$ 296 |
$ 4 |
$ 0 |
- |
| Actinium Pharmaceuticals, Inc. |
$ 30 |
- |
$ -27 |
- |
| Avenue Therapeutics, Inc. |
$ 18 |
- |
$ -12 |
- |
| Avadel Pharmaceuticals Plc |
$ 294 |
- |
$ 0 |
- |
| Aveo Pharmaceuticals Inc |
$ 398 |
$ 7 |
$ -66 |
- |
| Aoxing Pharmaceutical Company, Inc. |
$ 9 |
$ 30 |
$ -1 |
- |
| Axsome Therapeutics, Inc. |
$ 60 |
- |
$ 0 |
- |
| Biodelivery Sciences International Inc |
$ 137 |
$ 62 |
$ 5 |
- |
| Beigene, Ltd. |
$ 99,298 |
- |
$ -93 |
- |
| Dnib Unwind, Inc. |
- |
- |
$ 0 |
- |
| Biodel Inc |
- |
- |
$ 0 |
- |
| Bellicum Pharmaceuticals, Inc. |
$ 250 |
$ 0 |
$ -92 |
- |
| Bellerophon Therapeutics, Inc. |
$ 130 |
- |
$ -55 |
- |
| Biomarin Pharmaceutical Inc |
$ 14,445 |
$ 1,314 |
$ -117 |
- |
| Bristol Myers Squibb Co |
$ 83,726 |
$ 20,776 |
$ 975 |
25,000 |
| Fitlife Brands, Inc. |
- |
- |
$ 0 |
- |
| Blueprint Medicines Corp |
$ 3,285 |
$ 21 |
$ -148 |
- |
| Biostar Pharmaceuticals, Inc. |
$ 7 |
- |
$ 1 |
- |
| Biospecifics Technologies Corp |
$ 315 |
$ 27 |
$ 11 |
- |
| Baxalta Inc |
- |
- |
$ 0 |
- |
| Beyondspring Inc. |
$ 649 |
- |
$ -96 |
- |
| Calithera Biosciences, Inc. |
$ 218 |
$ 26 |
$ -28 |
- |
| Catabasis Pharmaceuticals Inc |
$ 39 |
- |
$ -27 |
- |
| Cymabay Therapeutics, Inc. |
$ 594 |
- |
$ -28 |
- |
| Cambrex Corp |
$ 1,848 |
$ 534 |
$ 102 |
- |
| Columbia Laboratories Inc |
- |
- |
$ 0 |
- |
| Carbylan Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Chemocentryx, Inc. |
$ 579 |
$ 83 |
$ 18 |
- |
| Celgene Corp |
$ 68,803 |
$ 12,998 |
$ 0 |
6,012 |
| Chembio Diagnostics, Inc. |
$ 97 |
$ 24 |
$ -6 |
- |
| Cempra, Inc. |
$ 122 |
$ 15 |
$ -77 |
- |
| Cerulean Pharma Inc. |
- |
- |
$ -39 |
- |
| Ceres Ventures, Inc. |
- |
- |
$ 0 |
- |
| Contrafect Corp |
$ 128 |
- |
$ -4 |
- |
| Chiasma, Inc |
$ 37 |
- |
$ -27 |
- |
| China Pharma Holdings, Inc. |
- |
- |
$ 0 |
- |
| Checkpoint Therapeutics, Inc. |
$ 94 |
- |
$ 0 |
- |
| Colucid Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Cellectar Biosciences, Inc. |
$ 19 |
- |
$ -14 |
- |
| Clearside Biomedical, Inc. |
$ 289 |
$ 0 |
$ -59 |
- |
| Celsion Corp |
$ 15 |
$ 1 |
$ -21 |
- |
| Clovis Oncology, Inc. |
$ 2,511 |
$ 56 |
$ -346 |
- |
| Chimerix Inc |
$ 240 |
$ 4 |
$ -71 |
- |
| Conatus Pharmaceuticals Inc. |
$ 107 |
$ 35 |
$ -17 |
- |
| Concert Pharmaceuticals, Inc. |
$ 922 |
$ 144 |
$ 0 |
- |
| Coronado Biosciences Inc |
- |
- |
$ 0 |
- |
| Global Green Inc. |
- |
- |
$ 0 |
- |
| Collegium Pharmaceutical, Inc |
$ 802 |
$ 28 |
$ -75 |
- |
| Corium International, Inc. |
$ 389 |
$ 34 |
$ -51 |
- |
| Corcept Therapeutics Inc |
$ 2,255 |
$ 159 |
$ 129 |
- |
| China Pharma Holdings, Inc. |
$ 13 |
$ 15 |
$ -21 |
- |
| Cumberland Pharmaceuticals Inc |
$ 101 |
$ 41 |
$ -9 |
- |
| Catalyst Pharmaceuticals, Inc. |
$ 230 |
- |
$ -18 |
- |
| Corbus Pharmaceuticals Holdings, Inc. |
$ 359 |
$ 3 |
$ -32 |
- |
| Cormedix Inc. |
$ 34 |
$ 0 |
$ -39 |
- |
| Cardiome Pharma Corp |
- |
- |
$ 0 |
- |
| Crispr Therapeutics Ag |
- |
- |
$ 0 |
- |
| Corvus Pharmaceuticals, Inc. |
$ 218 |
- |
$ -56 |
- |
| Cti Biopharma Corp |
$ 168 |
$ 25 |
$ -41 |
- |
| Catalent, Inc. |
$ 5,732 |
$ 2,300 |
$ 70 |
- |
| Contravir Pharmaceuticals, Inc. |
$ 9 |
- |
$ -8 |
- |
| Cyclacel Pharmaceuticals, Inc. |
- |
- |
$ -7 |
- |
| China Yct International Group, Inc. |
$ 20 |
$ 69 |
$ 13 |
- |
| Cymabay Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Cytokinetics Inc |
$ 384 |
$ 101 |
$ -21 |
- |
| Dara Biosciences, Inc. |
- |
- |
$ 0 |
- |
| Depomed Inc |
$ 422 |
$ 381 |
$ -102 |
- |
| Dermira, Inc. |
$ 373 |
$ 5 |
$ -303 |
- |
| Pronai Therapeutics Inc |
- |
- |
$ 0 |
- |
| Dipexium Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Dicerna Pharmaceuticals Inc |
$ 303 |
$ 2 |
$ -64 |
- |
| Durect Corp |
$ 316 |
$ 49 |
$ -4 |
- |
| Processa Pharmaceuticals, Inc. |
$ 327 |
- |
$ 0 |
- |
| Dynavax Technologies Corp |
$ 1,108 |
$ 0 |
$ -95 |
- |
| Eleven Biotherapeutics, Inc. |
$ 58 |
$ 1 |
$ -29 |
- |
| Endocyte Inc |
$ 452 |
$ 0 |
$ -55 |
- |
| Egalet Corp |
$ 27 |
$ 26 |
$ -69 |
- |
| Eagle Pharmaceuticals, Inc. |
$ 2,593 |
$ 268 |
$ 97 |
- |
| Elite Pharmaceuticals Inc |
$ 78 |
$ 8 |
$ 0 |
- |
| Emisphere Technologies Inc |
$ 35 |
$ 1 |
$ -2 |
- |
| Endo International Plc |
$ 1,230 |
$ 3,469 |
$ -2,035 |
- |
| Enanta Pharmaceuticals Inc |
$ 1,743 |
$ 131 |
$ 34 |
- |
| Epirus Biopharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Epizyme, Inc. |
$ 1,100 |
- |
$ -134 |
- |
| Esperion Therapeutics, Inc. |
$ 1,936 |
- |
$ -167 |
- |
| Evoke Pharma Inc |
$ 37 |
- |
$ -12 |
- |
| Eyegate Pharmaceuticals Inc |
$ 9 |
$ 0 |
$ -13 |
- |
| Fortress Biotech, Inc. |
$ 191 |
$ 203 |
$ -104 |
- |
| Fibrocell Science, Inc. |
$ 11 |
- |
$ -20 |
- |
| Fibrogen Inc |
$ 3,823 |
$ 126 |
$ -126 |
- |
| Flex Pharma, Inc. |
$ 91 |
$ 1 |
$ -34 |
- |
| Flamel Technologies Sa |
- |
- |
$ 0 |
- |
| Flexion Therapeutics Inc |
$ 906 |
- |
$ -137 |
- |
| Fresenius Medical Care Ag & Co. Kgaa |
- |
- |
$ 0 |
- |
| Antriabio, Inc. |
- |
- |
$ 0 |
- |
| Amicus Therapeutics Inc |
$ 2,371 |
$ 37 |
$ -284 |
- |
| Five Prime Therapeutics Inc |
$ 454 |
$ 40 |
$ -150 |
- |
| Fitlife Brands, Inc. |
$ 3 |
$ 20 |
$ -2 |
- |
| Futureworld Corp. |
- |
- |
$ 0 |
- |
| Galectin Therapeutics Inc |
$ 133 |
- |
$ -16 |
- |
| Globeimmune Inc |
- |
- |
$ 0 |
- |
| Gb Sciences Inc |
$ 85 |
- |
$ -16 |
- |
| Global Blood Therapeutics, Inc. |
$ 1,901 |
- |
$ -117 |
- |
| Gemphire Therapeutics Inc. |
$ 62 |
- |
$ -33 |
- |
| Geron Corp |
$ 604 |
- |
$ -33 |
- |
| Guardion Health Sciences, Inc. |
- |
$ 0 |
$ -6 |
- |
| Galmed Pharmaceuticals Ltd. |
$ 77 |
- |
$ 12 |
- |
| Glycomimetics Inc |
$ 603 |
- |
$ -33 |
- |
| Generex Biotechnology Corp |
$ 3 |
- |
$ -30 |
- |
| Genspera Inc |
- |
- |
$ 0 |
- |
| Genvec Inc |
$ 16 |
$ 0 |
$ -8 |
- |
| Global Green Inc. |
- |
- |
$ 0 |
- |
| Hutchison China Meditech Ltd |
$ 2,032 |
$ 241 |
$ -23 |
- |
| Heron Therapeutics, Inc. |
$ 2,253 |
$ 32 |
$ -197 |
- |
| HOSPIRA, INC. |
- |
- |
$ 0 |
- |
| Heat Biologics, Inc. |
$ 39 |
$ 2 |
$ -12 |
- |
| Horizon Pharma Plc |
$ 2,283 |
$ 1,158 |
$ -535 |
- |
| Imagenetix Inc |
- |
- |
$ 0 |
- |
| Ibio, Inc. |
$ 16 |
$ 0 |
$ -16 |
- |
| Intercept Pharmaceuticals Inc |
$ 1,729 |
$ 131 |
$ -360 |
- |
| Immune Design Corp. |
$ 146 |
$ 7 |
$ -52 |
- |
| Immunogen Inc |
$ 1,283 |
$ 115 |
$ -96 |
- |
| Imprimis Pharmaceuticals, Inc. |
$ 46 |
$ 27 |
$ -12 |
- |
| Immune Pharmaceuticals Inc |
$ 6 |
- |
$ -25 |
- |
| Immunocellular Therapeutics, Ltd. |
$ 9 |
- |
$ -18 |
- |
| Innocoll Holdings Plc |
$ 69 |
- |
$ 0 |
- |
| Insmed Inc |
$ 1,805 |
- |
$ -193 |
- |
| Insite Vision Inc |
- |
- |
$ 0 |
- |
| Insys Therapeutics, Inc. |
$ 511 |
$ 141 |
$ -228 |
- |
| Intellipharmaceutics International Inc. |
$ 17 |
- |
$ 0 |
- |
| Impax Laboratories Inc |
$ 1,435 |
$ 776 |
$ -469 |
- |
| Ironwood Pharmaceuticals Inc |
$ 2,583 |
$ 292 |
$ -143 |
- |
| Ionis Pharmaceuticals Inc |
- |
$ 508 |
$ -17 |
- |
| Intra-cellular Therapies, Inc. |
$ 1,041 |
$ 0 |
$ -98 |
- |
| Inotek Pharmaceuticals Corporation |
$ 82 |
- |
$ -38 |
- |
| Jaguar Health, Inc. |
$ 15 |
$ 4 |
$ -22 |
- |
| Jazz Pharmaceuticals Plc |
$ 9,665 |
$ 1,619 |
$ 488 |
- |
| Johnson & Johnson |
$ 347,998 |
$ 76,450 |
$ 1,300 |
126,500 |
| Juniper Pharmaceuticals Inc |
$ 98 |
$ 50 |
$ -1 |
- |
| Kalobios Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Kalvista Pharmaceuticals, Inc. |
$ 99 |
$ 3 |
$ -8 |
- |
| Humanigen, Inc |
$ 33 |
- |
$ -22 |
- |
| Kadmon Holdings, Inc. |
$ 330 |
$ 12 |
$ -80 |
- |
| Keryx Biopharmaceuticals Inc |
$ 568 |
$ 61 |
$ -163 |
- |
| Keyuan Petrochemicals, Inc. |
- |
- |
$ 0 |
- |
| Kindred Biosciences, Inc. |
$ 270 |
- |
$ -31 |
- |
| Kempharm, Inc |
$ 87 |
- |
$ -43 |
- |
| Karyopharm Therapeutics Inc. |
$ 711 |
$ 0 |
$ -129 |
- |
| China Shenghuo Pharmaceutical Holdings Inc |
- |
- |
$ 0 |
- |
| Kura Oncology, Inc. |
$ 481 |
- |
$ -35 |
- |
| Kythera Biopharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Lannett Co Inc |
$ 636 |
$ 640 |
$ 48 |
- |
| Lifevantage Corp |
$ 55 |
$ 194 |
$ 1 |
- |
| Ligand Pharmaceuticals Inc |
$ 4,031 |
$ 141 |
$ 13 |
- |
| Lilly Eli & Co |
$ 82,491 |
$ 22,871 |
$ -204 |
39,135 |
| Loxo Oncology, Inc. |
$ 3,994 |
- |
$ -149 |
- |
| Lipocine Inc. |
$ 35 |
- |
$ -21 |
- |
| Lexicon Pharmaceuticals, Inc. |
$ 885 |
$ 90 |
$ -129 |
- |
| Merrimack Pharmaceuticals Inc |
$ 1,109 |
- |
$ 468 |
- |
| Mabcure Inc. |
- |
- |
$ 0 |
- |
| Moleculin Biotech, Inc. |
$ 39 |
- |
$ -10 |
- |
| Seres Therapeutics, Inc. |
$ 313 |
$ 32 |
$ -89 |
- |
| Medicines Co |
$ 2,184 |
$ 68 |
$ -708 |
- |
| Medivation, Inc. |
- |
- |
$ 0 |
- |
| Mei Pharma, Inc. |
$ 80 |
$ 6 |
$ -20 |
- |
| Macrogenics Inc |
$ 870 |
$ 158 |
$ -20 |
- |
| Mmrglobal, Inc. |
- |
- |
$ 0 |
- |
| Mallinckrodt Plc |
$ 1,270 |
$ 3,222 |
$ 2,134 |
- |
| Mannkind Corp |
$ 198 |
$ 12 |
$ -117 |
- |
| Medicinova Inc |
$ 406 |
- |
$ -11 |
- |
| Merck & Co., Inc. |
$ 158,630 |
$ 40,122 |
$ 2,418 |
70,000 |
| Marinus Pharmaceuticals Inc |
$ 109 |
- |
$ -19 |
- |
| Mirati Therapeutics, Inc. |
$ 786 |
- |
$ -70 |
- |
| Mast Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Mylan N.v. |
$ 22,367 |
$ 12,118 |
$ 1,233 |
25,000 |
| Myos Rens Technology Inc. |
$ 8 |
$ 1 |
$ -4 |
- |
| Myovant Sciences Ltd. |
$ 1,258 |
- |
$ 0 |
- |
| Natures Sunshine Products Inc |
$ 182 |
$ 342 |
$ -14 |
- |
| Nabriva Therapeutics Plc |
$ 320 |
$ 5 |
$ -74 |
- |
| Novabay Pharmaceuticals, Inc. |
$ 51 |
$ 18 |
$ -7 |
- |
| Neos Therapeutics, Inc. |
$ 237 |
$ 25 |
$ -66 |
- |
| Neothetics, Inc. |
$ 27 |
- |
$ -10 |
- |
| Minerva Neurosciences, Inc. |
$ 279 |
- |
$ -32 |
- |
| China Nuokang Bio-pharmaceutical Inc. |
- |
- |
$ 0 |
- |
| Nektar Therapeutics |
$ 27,138 |
$ 308 |
$ -97 |
- |
| Newlink Genetics Corp |
$ 165 |
$ 29 |
$ -72 |
- |
| Novan, Inc. |
$ 50 |
$ 2 |
$ -37 |
- |
| Inergetics Inc |
- |
- |
$ 0 |
- |
| Nephrogenex, Inc. |
- |
- |
$ 0 |
- |
| Inspyr Therapeutics, Inc. |
$ 0 |
- |
$ 0 |
- |
| Neurotrope, Inc. |
$ 69 |
- |
$ -13 |
- |
| Nexvet Biopharma Plc |
$ 79 |
- |
$ -20 |
- |
| Novelion Therapeutics Inc. |
- |
- |
$ 0 |
- |
| Nivalis Therapeutics, Inc. |
$ 38 |
- |
$ -18 |
- |
| Novelos Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Northwest Biotherapeutics Inc |
$ 61 |
$ 0 |
$ -74 |
- |
| Northwest Biotherapeutics Inc |
- |
- |
$ 0 |
- |
| Ocera Therapeutics, Inc. |
$ 47 |
- |
$ -26 |
- |
| Ocular Therapeutix, Inc. |
$ 190 |
$ 2 |
$ -63 |
- |
| Oragenics Inc |
$ 76 |
- |
$ -7 |
- |
| Ohr Pharmaceutical Inc |
$ 13 |
- |
$ -21 |
- |
| Oncomed Pharmaceuticals Inc |
$ 120 |
$ 38 |
$ -39 |
- |
| Omeros Corp |
$ 674 |
$ 65 |
$ -53 |
- |
| Oncosec Medical Inc |
$ 55 |
- |
$ -29 |
- |
| Onconova Therapeutics, Inc. |
$ 6 |
$ 1 |
$ -24 |
- |
| Ophthotech Corp. |
$ 96 |
$ 215 |
$ 114 |
- |
| Opko Health, Inc. |
$ 3,446 |
$ 1,068 |
$ -309 |
- |
| Acer Therapeutics Inc. |
$ 3 |
- |
$ -7 |
- |
| Orexigen Therapeutics, Inc. |
$ 3 |
$ 75 |
$ -145 |
- |
| Oramed Pharmaceuticals Inc. |
$ 107 |
$ 5 |
$ 15 |
- |
| Oragenics Inc |
- |
- |
$ 0 |
- |
| Bioblast Pharma Ltd. |
- |
- |
$ 0 |
- |
| Otonomy, Inc. |
$ 114 |
$ 1 |
$ -90 |
- |
| Ovascience, Inc. |
$ 31 |
$ 0 |
$ -51 |
- |
| Phibro Animal Health Corp |
$ 1,776 |
$ 784 |
$ 62 |
- |
| Prestige Brands Holdings, Inc. |
$ 1,620 |
$ 1,026 |
$ 497 |
- |
| Puma Biotechnology, Inc. |
$ 2,299 |
- |
$ -292 |
- |
| Pacira Pharmaceuticals, Inc. |
$ 1,462 |
$ 287 |
$ -43 |
- |
| Aratana Therapeutics, Inc. |
$ 216 |
$ 26 |
$ -48 |
- |
| Pfizer Inc. |
$ 210,366 |
$ 53,168 |
$ 19,195 |
78,300 |
| Pfenex Inc. |
$ 129 |
- |
$ -71 |
- |
| Progenics Pharmaceuticals Inc |
$ 493 |
$ 12 |
$ -51 |
- |
| Pharmathene, Inc |
- |
$ 5 |
$ 114 |
- |
| Peak Pharmaceuticals, Inc. |
$ 7 |
- |
$ 0 |
- |
| Pozen Inc |
- |
- |
$ 0 |
- |
| Propanc Biopharma, Inc. |
- |
- |
$ -9 |
- |
| Avid Bioservices, Inc. |
$ 191 |
$ 65 |
$ -30 |
- |
| Perrigo Co Plc |
$ 11,562 |
$ 4,946 |
$ 120 |
- |
| Prophase Labs, Inc. |
$ 36 |
$ 10 |
$ 42 |
- |
| Prothena Corp Plc |
$ 1,418 |
$ 28 |
$ -153 |
- |
| Paratek Pharmaceuticals, Inc. |
$ 308 |
$ 13 |
$ -89 |
- |
| Protect Pharmaceutical Corp |
$ 1 |
- |
$ 0 |
- |
| Protalex Inc |
$ 12 |
- |
$ -5 |
- |
| Proto Script Pharmaceutical Corp |
$ 1 |
- |
$ 0 |
- |
| Ptc Therapeutics, Inc. |
$ 1,089 |
$ 194 |
$ -79 |
- |
| Patheon N.v. |
$ 5,116 |
- |
$ 0 |
- |
| Pain Therapeutics Inc |
$ 358 |
- |
$ -11 |
- |
| Portola Pharmaceuticals Inc |
$ 2,191 |
$ 27 |
$ -249 |
- |
| Palatin Technologies Inc |
$ 272 |
$ 82 |
$ 23 |
- |
| Pernix Therapeutics Holdings, Inc. |
$ 39 |
$ 146 |
$ -71 |
- |
| Provectus Biopharmaceuticals, Inc. |
$ 29 |
- |
$ -14 |
- |
| Phaserx, Inc. |
$ 3 |
- |
$ 4 |
- |
| Novelion Therapeutics Inc. |
- |
- |
$ 0 |
- |
| Uniqure N.v. |
$ 1,008 |
$ 13 |
$ -79 |
- |
| Ultragenyx Pharmaceutical Inc. |
$ 2,305 |
- |
$ -292 |
- |
| Ra Pharmaceuticals, Inc. |
$ 141 |
- |
$ 0 |
- |
| Rock Creek Pharmaceuticals, Inc. |
- |
- |
$ 0 |
5 |
| Radius Health, Inc. |
$ 1,484 |
- |
$ -261 |
- |
| Regeneron Pharmaceuticals Inc |
$ 36,310 |
$ 5,872 |
$ 1,199 |
- |
| Reliv International Inc |
$ 9 |
$ 42 |
$ -1 |
- |
| Recro Pharma, Inc. |
$ 220 |
$ 72 |
$ -50 |
- |
| Reata Pharmaceuticals Inc |
$ 624 |
$ 48 |
$ -48 |
- |
| Regulus Therapeutics Inc. |
$ 68 |
$ 0 |
$ -72 |
- |
| Rigel Pharmaceuticals Inc |
$ 555 |
$ 19 |
$ -78 |
- |
| Relypsa Inc |
- |
- |
$ 0 |
- |
| Rexahn Pharmaceuticals, Inc. |
$ 47 |
- |
$ -25 |
- |
| Rosetta Genomics Ltd. |
$ 1 |
$ 21 |
$ 54 |
- |
| Raptor Pharmaceutical Corp |
- |
- |
$ 0 |
- |
| Retrophin, Inc. |
$ 1,103 |
$ 158 |
$ -31 |
- |
| Ritter Pharmaceuticals Inc |
$ 149 |
- |
$ -8 |
- |
| Revance Therapeutics, Inc. |
$ 965 |
$ 0 |
$ -121 |
- |
| Ignyta, Inc. |
$ 1,516 |
- |
$ -120 |
- |
| Rxi Pharmaceuticals Corp |
$ 6 |
- |
$ -12 |
- |
| Sage Therapeutics, Inc. |
$ 5,546 |
- |
$ -257 |
- |
| Spring Bank Pharmaceuticals, Inc. |
$ 185 |
- |
$ -28 |
- |
| Sciclone Pharmaceuticals Inc |
$ 594 |
$ 172 |
$ 43 |
- |
| Sucampo Pharmaceuticals, Inc. |
$ 1,171 |
$ 250 |
$ -151 |
- |
| Scynexis Inc |
$ 38 |
$ 0 |
$ -25 |
- |
| Sagent Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Signpath Pharma, Inc. |
- |
- |
$ 0 |
- |
| Synergy Pharmaceuticals, Inc. |
$ 493 |
- |
$ -244 |
- |
| Shire Plc |
- |
$ 15,161 |
$ 4,272 |
- |
| Shire Plc |
- |
- |
$ 0 |
- |
| Siga Technologies Inc |
- |
- |
$ 0 |
- |
| Siga Technologies Inc |
- |
$ 6 |
$ -32 |
- |
| Sunset Island Group, Inc |
- |
- |
$ 0 |
- |
| Skystar Bio-pharmaceutical Co |
- |
- |
$ 0 |
- |
| Sibannac, Inc. |
$ 2 |
$ 0 |
$ 0 |
- |
| Sunesis Pharmaceuticals Inc |
$ 90 |
$ 3 |
$ -35 |
- |
| Madrigal Pharmaceuticals, Inc. |
- |
- |
$ -31 |
- |
| Sophiris Bio Inc. |
$ 66 |
$ 0 |
$ -9 |
- |
| Spectrum Pharmaceuticals Inc |
$ 1,845 |
$ 128 |
$ -91 |
- |
| Sarepta Therapeutics, Inc. |
$ 5,113 |
$ 155 |
$ -51 |
- |
| Sierra Oncology, Inc. |
$ 99 |
- |
$ -42 |
- |
| Steadymed Ltd. |
$ 103 |
$ 1 |
$ 16 |
- |
| Stemline Therapeutics Inc |
$ 407 |
$ 1 |
$ -68 |
- |
| Supernus Pharmaceuticals Inc |
$ 2,599 |
$ 302 |
$ 57 |
- |
| Sinovac Biotech Ltd |
- |
- |
$ 0 |
- |
| Savara Inc. |
$ 261 |
- |
$ -30 |
- |
| Growblox Sciences, Inc. |
- |
- |
$ 0 |
- |
| Synthetic Biologics, Inc. |
$ 44 |
- |
$ -15 |
- |
| Syros Pharmaceuticals, Inc. |
$ 331 |
- |
$ -54 |
- |
| Taro Pharmaceutical Industries Ltd |
- |
- |
$ 0 |
- |
| Theravance Biopharma, Inc. |
$ 1,295 |
$ 2 |
$ -319 |
- |
| Teva Pharmaceutical Industries Ltd |
$ 20,582 |
$ 23,144 |
$ -11,653 |
- |
| Threshold Pharmaceuticals Inc |
$ 39 |
- |
$ -13 |
- |
| Innoviva, Inc. |
- |
$ 217 |
$ 134 |
- |
| Tokai Pharmaceuticals Inc |
- |
- |
$ -30 |
- |
| Tetralogic Pharmaceuticals Corp |
- |
- |
$ 0 |
- |
| Tonix Pharmaceuticals Holding Corp. |
$ 25 |
- |
$ -21 |
- |
| Tocagen Inc |
$ 206 |
- |
$ 0 |
- |
| Tianyin Pharmaceutical Co., Inc. |
- |
- |
$ 0 |
- |
| Tapimmune Inc. |
$ 31 |
- |
$ -11 |
- |
| Trevena Inc |
$ 108 |
- |
$ -72 |
- |
| Transcept Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Tesaro, Inc. |
$ 2,807 |
$ 223 |
$ -496 |
- |
| Titan Pharmaceuticals Inc |
$ 20 |
$ 0 |
$ -14 |
- |
| Tetraphase Pharmaceuticals Inc |
$ 167 |
$ 10 |
$ -115 |
- |
| Therapeuticsmd, Inc. |
$ 1,216 |
$ 17 |
$ -77 |
- |
| Shineco, Inc. |
$ 33 |
$ 16 |
$ 3 |
- |
| United Therapeutics Corp |
$ 5,098 |
$ 1,725 |
$ 418 |
- |
| Vaccinogen Inc |
- |
- |
$ 0 |
- |
| Viking Therapeutics, Inc. |
$ 165 |
- |
$ -20 |
- |
| Vanda Pharmaceuticals Inc. |
$ 667 |
$ 165 |
$ -16 |
- |
| Vertex Pharmaceuticals Inc |
$ 41,482 |
$ 2,489 |
$ 92 |
- |
| Valeant Pharmaceuticals International, Inc. |
$ 6,087 |
$ 8,724 |
$ 2,404 |
- |
| Versartis, Inc. |
$ 54 |
- |
$ -85 |
- |
| Verastem, Inc. |
$ 177 |
- |
$ -68 |
- |
| Vitae Pharmaceuticals, Inc |
- |
- |
$ 0 |
- |
| Vital Therapies Inc |
$ 239 |
- |
$ -52 |
- |
| Vtv Therapeutics Inc. |
$ 20 |
$ 0 |
$ -55 |
- |
| Vivus Inc |
$ 41 |
$ 65 |
$ -31 |
- |
| World Health Energy Holdings, Inc. |
$ 9 |
- |
$ 0 |
- |
| Wuxi Pharmatech (cayman) Inc. |
- |
- |
$ 0 |
- |
| Xbiotech Inc. |
$ 172 |
- |
$ -33 |
- |
| Xenon Pharmaceuticals Inc. |
$ 91 |
$ 0 |
$ -31 |
- |
| Xencor Inc |
$ 1,404 |
$ 36 |
$ -49 |
- |
| Xenoport Inc |
- |
- |
$ 0 |
- |
| Xoma Corp |
$ 216 |
$ 53 |
$ 6 |
- |
| Zafgen, Inc. |
$ 189 |
- |
$ -48 |
- |
| Zogenix, Inc. |
$ 1,393 |
$ 27 |
$ -127 |
- |
| Zosano Pharma Corp |
$ 166 |
- |
$ -29 |
- |
| Zs Pharma, Inc. |
- |
- |
$ 0 |
- |
| Zoetis Inc. |
$ 41,951 |
$ 5,307 |
$ 862 |
- |
| Zynerba Pharmaceuticals, Inc. |
$ 142 |
- |
$ -32 |
- |
| Ovid Therapeutics Inc. |
$ 248 |
- |
$ -65 |
- |
| Shuttle Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Tyme Technologies, Inc. |
$ 198 |
- |
$ 0 |
- |
| Plx Pharma Inc. |
$ 37 |
- |
$ 0 |
- |
| Athenex, Inc. |
$ 931 |
- |
$ 0 |
- |
| Iaso Biomed, Inc. |
- |
- |
$ 0 |
- |
| Innovation Pharmaceuticals Inc. |
$ 62 |
- |
$ 0 |
- |
| Luckycom Pharmaceuticals Inc. |
$ 64 |
- |
$ 0 |
- |
| Nuo Therapeutics, Inc. |
$ 4 |
- |
$ 0 |
- |
| Synlogic, Inc. |
$ 155 |
- |
$ 0 |
- |
| Molecular Templates, Inc. |
$ 140 |
- |
$ 0 |
- |
| Alpine Immune Sciences, Inc. |
$ 70 |
- |
$ 0 |
- |
| Apellis Pharmaceuticals, Inc. |
$ 813 |
- |
$ 0 |
- |
| Major Pharmaceutical Preparations Industry |
$ 1,612,473 |
$ 367,373 |
$ 7,775 |
449,225 |
| Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Major Pharmaceutical Preparations Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Major Pharmaceutical Preparations Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter 22.22 % of companies, who provided earning outlook within Major Pharmaceutical Preparations Industry, have reiterated their earnings per share outlook for the current fiscal year unchanged. |
Earnings Estimates
decrease
Pessimism dominates within Major Pharmaceutical Preparations Industry, as most of the businesses cut their earnings guidance, staggering 44.44 % have revised down earnings outlook. Overall earnings expectations for the Major Pharmaceutical Preparations Industry were cut by %, to the annual earnings expectation of %. |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
 |
% Industry
Expected EPS Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Earnings Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
In the current quarter 33.33 % of companies, who have issued revenue expectation within Major Pharmaceutical Preparations Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year. |
Sales Expectations unchanged
As even more corporations reiterate their sales projections, 66.67 % of businesses within Major Pharmaceutical Preparations Industry, while corporate executives do not expect any change of economic environment. |
Sales Outlook decrease
In Major Pharmaceutical Preparations Industry, there were no sales guidance decreases |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
|
% Industry
Expected Revenue Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Revenue Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
| Cardiovascular Segment |
| Revenues |
Income |
|
-3.79% |
5.25% |
53.25% |
648.7% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Neuroscience Segment |
| Revenues |
Income |
|
- |
- |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Anti-Infective Segment |
| Revenues |
Income |
|
14.75% |
-7.45% |
23.14% |
-12.12% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Respiratory Segment |
| Revenues |
Income |
|
-3.79% |
5.25% |
53.25% |
648.7% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Arthritis & Pain Segment |
| Revenues |
Income |
|
24.3% |
7.73% |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Urology Segment |
| Revenues |
Income |
|
-3.79% |
5.25% |
53.25% |
648.7% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Oncology Segment |
| Revenues |
Income |
|
9.97% |
1.68% |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Endocrine Segment |
| Revenues |
Income |
|
-34.8% |
-30.47% |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
|
|
